Skip to main content
Top
Published in: Clinical Rheumatology 8/2016

01-08-2016 | Original Article

Association between arterial stiffness, disease activity and functional impairment in ankylosing spondylitis patients: a cross-sectional study

Authors: Claudiu Avram, Răzvan Gabriel Drăgoi, Horațiu Popoviciu, Mihai Drăgoi, Adina Avram, Elena Amaricăi

Published in: Clinical Rheumatology | Issue 8/2016

Login to get access

Abstract

Cardiovascular risk is an important factor for increased morbidity and mortality in patients with ankylosing spondylitis. The aim of this study is to assess arterial stiffness in relation to the disease activity and functional limitation in patients with ankylosing spondylitis. Twenty-four patients (mean age 45.8 ± 11.7 years) suffering of ankylosing spondylitis (disease duration 11.1 ± 5.1 years) and 24 gender and age-matched healthy controls were included in the study. Clinical, biological, and functional status of ankylosing spondylitis patients was recorded. Arterial stiffness was assessed by measuring pulse wave velocity (PWV) and pulse wave analysis (PWA) was performed using applanation tonometry. We found significant differences between ankylosing spondylitis patients and healthy controls in regard to PWV (p = 0.047), aortic augmentation pressure—AP (p = 0.028), augmentation index—AIx (p = 0.038) and aortic augmentation index adjusted for heart rate—AIx75 (p = 0.011). PWV and AIx75 were significantly associated with the disease functioning score—BASFI (p = 0.012, r = 0.504; p = 0.041, r = 0.421). Aortic AP and augmentation indexes (AIx and AIx75) were all associated to ASDAS score (p = 0.028, r = 0.448; p = 0.005, r = 0.549; p = 0.025, r = 0.455). Our study showed that ankylosing spondylitis patients have a higher arterial stiffness than the age-matched controls, leading to an increased cardiovascular risk. We found that arterial stiffness is positively associated with disease activity and functional impairment. Chronic spondiloarthropaties should be screened for arterial stiffness, even in the absence of traditional cardiovascular risk factors, in order to benefit from primary prevention measures.
Literature
1.
go back to reference Klippel JH, Stone JH, Crofford LJ, White PH (2008) Primer on the rheumatic diseases. Springer, New YorkCrossRef Klippel JH, Stone JH, Crofford LJ, White PH (2008) Primer on the rheumatic diseases. Springer, New YorkCrossRef
2.
go back to reference Sveaas SH, Berg IJ, Provan SA et al (2014) Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study. PLoS One 9(9), e108688CrossRefPubMedPubMedCentral Sveaas SH, Berg IJ, Provan SA et al (2014) Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study. PLoS One 9(9), e108688CrossRefPubMedPubMedCentral
3.
go back to reference Mathieu S, Gossec L, Dougados M et al (2011) Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res 63:557–563CrossRef Mathieu S, Gossec L, Dougados M et al (2011) Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res 63:557–563CrossRef
4.
go back to reference Bremander A, Petersson IF, Bergman S et al (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 63:550–556CrossRef Bremander A, Petersson IF, Bergman S et al (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 63:550–556CrossRef
5.
go back to reference Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70:1921–1925CrossRefPubMed Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70:1921–1925CrossRefPubMed
6.
go back to reference Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA et al (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585–592CrossRefPubMed Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA et al (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585–592CrossRefPubMed
7.
go back to reference Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331CrossRefPubMed Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331CrossRefPubMed
8.
go back to reference Han C, Robinson DW Jr, Hackett M et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed Han C, Robinson DW Jr, Hackett M et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed
9.
go back to reference Nurmohamed MT, van der Horst-Bruinsma I, Maksymowych WP (2012) Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights. Curr Rheumatol Rep 14:415–421CrossRefPubMed Nurmohamed MT, van der Horst-Bruinsma I, Maksymowych WP (2012) Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights. Curr Rheumatol Rep 14:415–421CrossRefPubMed
11.
go back to reference Cavalcante JL, Lima JA, Redheuil A et al (2011) Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57:1511–1522CrossRefPubMed Cavalcante JL, Lima JA, Redheuil A et al (2011) Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57:1511–1522CrossRefPubMed
12.
go back to reference Sakuragi S, Abhayaratna WP (2010) Arterial stiffness: methods of measurement, physiologic determinants and prediction of cardiovascular outcomes. Int J Cardiol 138:112–118CrossRefPubMed Sakuragi S, Abhayaratna WP (2010) Arterial stiffness: methods of measurement, physiologic determinants and prediction of cardiovascular outcomes. Int J Cardiol 138:112–118CrossRefPubMed
13.
go back to reference Laurent S, Boutouyrie P (2007) Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol 12:S45–S50 Laurent S, Boutouyrie P (2007) Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol 12:S45–S50
14.
go back to reference Rudwaleit M, van der Heijde D, Landewe R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783CrossRefPubMed Rudwaleit M, van der Heijde D, Landewe R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783CrossRefPubMed
15.
go back to reference Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
16.
go back to reference Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
17.
go back to reference Machado P, Landewé R, Lie E et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47–53CrossRefPubMed Machado P, Landewé R, Lie E et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47–53CrossRefPubMed
18.
go back to reference Nichols WW (2005) Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 18:3S–10SCrossRefPubMed Nichols WW (2005) Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 18:3S–10SCrossRefPubMed
19.
go back to reference Jain S, Khera R, Corrales-Medina VF et al (2014) Inflammation and arterial stiffness in humans. Atherosclerosis 237:381–390CrossRefPubMed Jain S, Khera R, Corrales-Medina VF et al (2014) Inflammation and arterial stiffness in humans. Atherosclerosis 237:381–390CrossRefPubMed
20.
go back to reference Berg IJ, van der Heijde D, Dagfinrud H et al (2015) Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study. J Rheumatol 42:645–653CrossRefPubMed Berg IJ, van der Heijde D, Dagfinrud H et al (2015) Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study. J Rheumatol 42:645–653CrossRefPubMed
21.
go back to reference Bodnár N, Kerekes G, Seres I et al (2011) Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol 38:723–729CrossRefPubMed Bodnár N, Kerekes G, Seres I et al (2011) Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol 38:723–729CrossRefPubMed
22.
go back to reference Mathieu S, Joly H, Baron G et al (2008) Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology 47:1203–1207CrossRefPubMed Mathieu S, Joly H, Baron G et al (2008) Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology 47:1203–1207CrossRefPubMed
23.
go back to reference Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA et al (2009) The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore) 88:358–365CrossRef Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA et al (2009) The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore) 88:358–365CrossRef
24.
go back to reference Angel K, Provan SA, Gulseth HL et al (2010) Tumor necrosis factor-α antagonists improve aortic stiffness in patients with inflammatory arthropathies. Hypertension 55:333–338CrossRefPubMed Angel K, Provan SA, Gulseth HL et al (2010) Tumor necrosis factor-α antagonists improve aortic stiffness in patients with inflammatory arthropathies. Hypertension 55:333–338CrossRefPubMed
25.
go back to reference Salaffi F, Ciapetti A, Carotti M et al (2014) Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis. Health Qual Life Outcomes 12:129. doi:10.1186/s12955-014-0129-9 CrossRefPubMedPubMedCentral Salaffi F, Ciapetti A, Carotti M et al (2014) Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis. Health Qual Life Outcomes 12:129. doi:10.​1186/​s12955-014-0129-9 CrossRefPubMedPubMedCentral
26.
27.
go back to reference Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904CrossRefPubMedPubMedCentral Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904CrossRefPubMedPubMedCentral
28.
go back to reference Capkin E, Karkucak M, Kiris A et al (2012) Anti-TNF-a therapy may not improve arterial stiffness in patients with AS: a 24-week follow-up. Rheumatology 51:910–914CrossRefPubMed Capkin E, Karkucak M, Kiris A et al (2012) Anti-TNF-a therapy may not improve arterial stiffness in patients with AS: a 24-week follow-up. Rheumatology 51:910–914CrossRefPubMed
Metadata
Title
Association between arterial stiffness, disease activity and functional impairment in ankylosing spondylitis patients: a cross-sectional study
Authors
Claudiu Avram
Răzvan Gabriel Drăgoi
Horațiu Popoviciu
Mihai Drăgoi
Adina Avram
Elena Amaricăi
Publication date
01-08-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 8/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3297-7

Other articles of this Issue 8/2016

Clinical Rheumatology 8/2016 Go to the issue